Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.
about
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trialA randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulenceT-type Ca(2+) channel modulation by otilonium bromide.IBS and the role of otilonium bromide.Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.Prevalence and risk factors of irritable bowel syndrome in Asia.The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III.A randomised, controlled study of small intestinal motility in patients treated with sacral nerve stimulation for irritable bowel syndrome.Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.The current prevalence of irritable bowel syndrome in AsiaIrritable bowel syndrome in the United States: prevalence, symptom patterns and impact.Prevalence and management of abdominal cramping and pain: a multinational survey.Prevalence of irritable bowel syndrome: a community based study from northern India.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.Factors associated with irritable bowel syndrome symptoms in hemodialysis patientsIrritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review.Markers for visceral hypersensitivity in patients with irritable bowel syndrome.Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt.Functional bowel disorders and irritable bowel syndrome in Europe.Familial aggregation of irritable bowel syndrome: a prospective studyGastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceQuality of life and illness costs in irritable bowel syndrome.The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis.Systematic review: the influence of geography and ethnicity in irritable bowel syndrome.Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.Irritable bowel syndrome in developing countries--a disorder of civilization or colonization?Psychopharmacological treatment and psychological interventions in irritable bowel syndrome.Irritable bowel syndrome: diagnosis and pathogenesis.Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders.Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia.Applying case definition criteria to irritable bowel syndromeIrritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.Constructive thinking, rational intelligence and irritable bowel syndromePrevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic surveyThe epidemiology of irritable bowel syndromeMucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.Post-infectious irritable bowel syndrome: the past, the present and the future.Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.
P2860
Q24595301-C18BCCE6-C5A9-49E7-B1C5-F285B2052651Q28295210-E0894201-B270-45FD-9B76-8821DE549E69Q30432447-9B80E34B-9A3A-4FDC-9B9F-15D8DF792C2CQ33456428-538B7ADD-DBC9-460D-AB06-A1216E36D957Q33531535-C22E66F7-5964-4442-8925-D7DB497B726DQ33890440-AC47FE0F-640C-477F-B970-BF4C68B749B9Q33890526-ACE44052-AFF3-4E00-BD8C-9CBF618B438FQ33904432-8CB01DB8-CDDC-4E78-B174-FF1D631999F4Q34168626-4FC1507F-FF2B-4CDA-8ACF-EC4707B1198CQ34298271-C67D6109-AEA2-4FDB-A8AA-47451C390350Q34423405-45D22BFC-528F-42FD-99EC-41B6593E9E71Q34547643-F95E6F6F-55D9-42E3-B6E8-683F96469F82Q34588809-1AE843FD-00D6-474E-8E56-3F63856A59BBQ34626602-737509FE-2025-4F90-8498-18AE8C9A971FQ34630501-F6ABBBBE-2B27-40B3-AB3D-F761E69E4996Q34863240-CBAE1279-146D-4592-B4F7-D0A813856996Q34988722-F625ED69-ACC2-4765-9638-299FAAE07DE9Q34993716-CE193F61-58AC-4213-BADC-1780F274449DQ35185813-48B9E640-4B05-45D8-A1FB-F5740968E92CQ35548221-9B4FD8DB-66B2-46EA-A79E-CD340183179DQ35553251-4CC78A64-4B04-4A67-9B18-106EACF5CB2CQ35596202-A6F7AA3A-EDDC-45D0-B01C-76DD71BAC65EQ35768888-6A1C21A6-976C-4F67-8CEC-D6FDCF0C77D6Q35838021-50FB17C4-8E9F-40D9-BA73-482E271CF3F5Q35956104-93649A6C-79D7-4284-9617-BED7A5A15FDAQ36072578-2658AA24-CD4A-42EF-A5F0-486EB936494CQ36103128-A2AB28A1-CDBB-48AB-882A-2B0D08460CFEQ36139386-0A425A93-B86E-4658-B555-7879BBFF98DDQ36203967-25D0FE6B-B0D4-43E3-B79D-BDADDEF504CDQ36310403-1DB16FE7-CE43-4D0F-925B-D49BFDEBFD3CQ36404927-8868C31D-9160-411B-B383-FB6BF3F7B33EQ36698651-D1D02580-B08F-4D4D-87D3-F493E0F308C5Q36740848-9A7EF5E0-3F90-425C-8646-4B4BEE1476C9Q37120953-7B00360A-634B-4A72-9F83-1608EC1D4255Q37250345-9AF71DC7-9316-4D08-B80E-247D4DFA596BQ37542854-8108333F-6E0E-49D9-AB48-73F6CCF7065BQ37577760-B25BCA13-4F3F-44A3-B16A-6ABE5F86DC70Q37844488-1C2785E0-DCBE-43A7-93EE-8EE70845BD2AQ37858647-4B3D7E15-9F82-4A74-8408-BAAAEBDCDC07Q38011936-BCD6C359-011B-49D3-8785-E89E40E2D27C
P2860
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Irritable bowel syndrome preva ...... teria in a general population.
@en
Irritable bowel syndrome preva ...... teria in a general population.
@nl
type
label
Irritable bowel syndrome preva ...... teria in a general population.
@en
Irritable bowel syndrome preva ...... teria in a general population.
@nl
prefLabel
Irritable bowel syndrome preva ...... teria in a general population.
@en
Irritable bowel syndrome preva ...... teria in a general population.
@nl
P2093
P1476
Irritable bowel syndrome preva ...... teria in a general population.
@en
P2093
Caldwell E
Díaz-Rubio M
P304
P356
10.1080/00365520152584770
P577
2001-11-01T00:00:00Z